Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2023-05-03 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) notifying them under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. It informs about the receipt of permission (Form CT-20) from a regulatory authority (Central Drugs Standard Control Organisation) for import and sale of a pharmaceutical product. The content is an announcement of a regulatory approval event relevant to the company, not a financial report, earnings release, or management discussion. The document length is short (1638 characters) and it serves as an official intimation to the stock exchanges. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-05-03 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) confirming that AstraZeneca Pharma India Limited does not meet the criteria for being classified as a Large Corporate under a specific SEBI circular related to fund raising by issuance of debt securities. It is a regulatory compliance communication rather than a financial report or announcement of financial results. The document is short (1208 characters) and serves as a confirmation or declaration for regulatory record-keeping. It does not contain financial data, management discussion, or report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and confirmations that do not fit other specific categories.
2023-04-25 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates, referencing compliance with SEBI Listing Obligations and Disclosure Requirements. It is an announcement about a specific event related to share certificates, not a financial report, meeting material, or management discussion. The content fits the category of a regulatory announcement related to shareholding and compliance but does not report on shareholding thresholds or insider transactions. It is not a report publication or certification. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-04-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the lost share certificates and the shareholder involved. There is no financial data, report, or presentation included. The document is an official notification related to share certificates, which fits the category of Regulatory Filings (RNS) as it is a regulatory announcement that does not fit into more specific categories like share issue or director dealings.
2023-04-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization procedures for securities for the period 01.03.2023 to 31.03.2023. It is addressed to stock exchanges and the company secretary. The document is short (3287 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities dematerialization and transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate filing rather than any other specific report type.
2023-04-13 English
As required under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith a Certificate issued by the Practicing Company Secretary ....
Regulatory Filings
2023-04-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.